Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab vs Golimumab in RA Patients Who Failed TNF-alpha Antagonists
NCT01217814Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Nov 2010
- Primary completion
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of sarilumab in rheumatoid arthritis (RA), sponsored by Sanofi. Started Nov 2010; status: terminated.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01217814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01217814.